Mistletoe in the treatment of cancer

The use of mistletoe in the treatment of cancer originated with Rudolf Steiner, the founder of Anthroposophy. He compared the parasitic nature of the mistletoe plant to that of cancer, and believed that cancer represents a faltering of the body’s immune defences.

Thus, over the last 90 years, preparations of mistletoe in the treatment of cancer have been prescribed and used in mainly Central and Northern Europe. Currently, roughly 70% of all cancer patients in these countries receive mistletoe that are prescribed by their licensed physicians and paid for by the national health insurance systems, making mistletoe one of the most commonly prescribed anticancer medication.

Mistletoe therapy

Approximately 85% of patients receive mistletoe, who get their treatment according to the Gorter Model. Anthroposophical mistletoe preparations are manufactured and available as Iscador® or ABNOBAViscum®. They are applied subcutaneously twice a week. For a number of reasons, ABNOBAViscum®. is preferred.

Under the guidance of Robert Gorter, MD, PhD, Director of the Gorter Model, as their “Doktorvater”, six young doctors received their doctor’s title through clinical research with mistletoe and other collaborating academic institutions, showing great benefit in immune response towards cancer cells and improvement of NK cell function etc.

The aim of this website is to give information on the use of mistletoe in the treatment of cancer. All information is provided by ABNOBA and The Gorter Model.